Secondly, comprehensive functional and mechanistic studies provided the first evidence that FOXD1 promoted CTC formation and metastasis in BC by regulating the RalA-ANXA2-Src complex activating ERK1/2 signaling. The gene discussed is FOXD1; the disease is breast cancer.